KDA Group

KDA Group CROIC

The Cash Return on Invested Capital (CROIC) of KDA Group (KDA.V) as of Oct 26, 2026 is -34.28 %. In the previous year, Cash Return on Invested Capital (CROIC) was -30.27 % — a change of 13.27% (lower).

CROIC

-34.28 %

YoY

13.27%

Last updated:

Cash Return on Invested Capital (CROIC) of KDA Group is 2025 -34.28 % . Cash Return on Invested Capital (CROIC) of KDA Group was 2024 -30.27 % . It decreases by 13.27% lower compared to the previous year.

The KDA Group CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
3.44 CAD
Jan 1, 2019
-88.29 CAD
Jan 1, 2020
61.61 CAD
Jan 1, 2021
29.56 CAD
Jan 1, 2022
31.25 CAD
Jan 1, 2023
-17.93 CAD
Jan 1, 2024
-30.27 CAD
Jan 1, 2025
-34.28 CAD
The KDA Group CROIC history
YEARCROICYoY
-34.28 %+13.27%
-30.27 %+68.82%
-17.93 %-157.36%
31.25 %+5.71%
29.56 %-52.02%
61.61 %-169.78%
-88.29 %-2,670.18%
3.44 %-155.60%
-6.18 %-65.62%
-17.97 %+24.08%
-14.48 %+8,625.89%
-0.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KDA Group Stock analysis

What does KDA Group do? KDA Group, Inc. generates revenue through its Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Technology segments. The Pharmacy Services segment provides training, consulting, and replacement services for healthcare professionals. The Pharmaceutical Solutions segment develops and integrates technological platforms for healthcare professionals. The Pharmaceutical Technology segment offers KRX, KRX DENTAL, and ADRX platforms, while ZRx Digital Prescriber is an electronic prescriber software for authorized healthcare providers. Subsidiaries like Alliance Pharma Operations Inc. and Elitis Pharma Inc. support these services. Clients include healthcare professionals who require training, consulting, and technological solutions. The Pharmacy Services segment targets professional resource needs in healthcare, while Pharmaceutical Solutions and Technology segments serve healthcare professionals with integrated platforms and digital tools. Subsidiaries such as Logistik Pharma Inc. and Groupe Technologique KDA Inc. contribute to the company's service delivery. Pharmaceutical Technology platforms like KRX, KRX DENTAL, and ADRX are sold to healthcare professionals seeking digital solutions. ZRx Digital Prescriber is utilized by authorized prescribers for medication and treatment management. The company's subsidiaries operate within the segments to deliver specialized services, ensuring comprehensive solutions for healthcare providers. KDA Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KDA Group stock

Cash Return on Invested Capital (CROIC) of KDA Group is -34.28 % in 2025.

Cash Return on Invested Capital (CROIC) of KDA Group changed from -30.27 % to -34.28 %, representing a 13.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) KDA Group since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s KDA Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — KDA Group

All Key Metrics — KDA Group